SPINOPHILIN: A multiplayer tumor suppressor

Allen, 1997, Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines, Proc Natl Acad Sci USA, 94, 9956, 10.1073/pnas.94.18.9956 Satoh, 1998, Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites, J Biol Chem, 273, 3470, 10.1074/jbc.273.6.3470 Carnero, 2012, Spinophilin: a new tumor suppressor at 17q21, Curr Mol Med, 12, 528, 10.2174/156652412800619987 Sarrouilhe, 2006, Spinophilin: from partners to functions, Biochimie, 88, 1099, 10.1016/j.biochi.2006.04.010 Caduff, 1999, Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast, Virchows Arch, 434, 517, 10.1007/s004280050377 Smith, 1993, Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-Q21, Am J Hum Genet, 52, 767 Cohen, 1993, Linkage of a major breast cancer gene to chromosome 17q12-21:results from 15 Edinburgh families, Am J Hum Genet, 52, 723 Porter, 2005, Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21, Br J Surg, 81, 1512, 10.1002/bjs.1800811038 Porter, 1993, Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals, Br J Surg, 80, 1381, 10.1002/bjs.1800801108 Easton, 1993, Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium, Am J Hum Genet, 52, 678 Abujiang, 1998, Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers, Oncogene, 17, 3029, 10.1038/sj.onc.1202230 Barnes, 2004, The identification of a second actin-binding region in spinophilin/neurabin II, Brain Res Mol Brain Res, 124, 105, 10.1016/j.molbrainres.2003.12.020 Grossman, 2004, Spinophilin is phosphorylated by Ca2+/calmodulin-dependent protein kinase II resulting in regulation of its binding to F-actin, J Neurochem, 90, 317, 10.1111/j.1471-4159.2004.02491.x Futter, 2005, Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5), Proc Natl Acad Sci USA, 102, 3489, 10.1073/pnas.0409802102 Hsieh-Wilson, 2003, Phosphorylation of spinophilin modulates its interaction with actin filaments, J Biol Chem, 278, 1186, 10.1074/jbc.M205754200 Vivo, 2001, The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein, J Biol Chem, 276, 14161, 10.1074/jbc.M006845200 Wera, 1995, Serine/threonine protein phosphatases, Biochem J, 311, 17, 10.1042/bj3110017 Egloff, 1997, Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1, EMBO J, 16, 1876, 10.1093/emboj/16.8.1876 Rebelo, 2015, Protein phosphatase 1 is a key player in nuclear events, Cell Signal, 27, 2589, 10.1016/j.cellsig.2015.08.007 Cohen, 1990, Protein serine/threonine phosphatases; an expanding family, FEBS Lett, 268, 355, 10.1016/0014-5793(90)81285-V Dancheck, 2011, Molecular investigations of the structure and function of the protein phosphatase 1-spinophilin-inhibitor 2 heterotrimeric complex, Biochemistry, 50, 1238, 10.1021/bi101774g Peti, 2013, Structural basis for protein phosphatase 1 regulation and specificity, FEBS J, 280, 596, 10.1111/j.1742-4658.2012.08509.x Nelson, 1997, High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein, J Biol Chem, 272, 4528, 10.1074/jbc.272.7.4528 Sasaki, 1990, Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas, Jpn J Cancer Res, 81, 1272, 10.1111/j.1349-7006.1990.tb02690.x Berndt, 1999, Protein dephosphorylation and the intracellular control of the cell number, Front Biosci, 4, D22, 10.2741/Berndt Terry-Lorenzo, 2002, The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits, J Biol Chem, 277, 27716, 10.1074/jbc.M203365200 Hirschi, 2010, An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein, Nat Struct Mol Biol, 17, 1051, 10.1038/nsmb.1868 MacMillan, 1999, Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms, J Biol Chem, 274, 35845, 10.1074/jbc.274.50.35845 Ragusa, 2010, Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites, Nat Struct Mol Biol, 17, 459, 10.1038/nsmb.1786 Ragusa, 2011, Flexibility in the PP1:spinophilin holoenzyme, FEBS Lett, 585, 36, 10.1016/j.febslet.2010.11.022 Heroes, 2013, The PP1 binding code: a molecular-lego strategy that governs specificity, FEBS J, 280, 584, 10.1111/j.1742-4658.2012.08547.x Hsieh-Wilson, 1999, Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1, Biochemistry, 38, 4365, 10.1021/bi982900m Verdugo-Sivianes, 2021, Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells, Theranostics, 11, 3452, 10.7150/thno.53572 Terry-Lorenzo, 2002, Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton, J Biol Chem, 277, 46535, 10.1074/jbc.M206960200 Bielas, 2007, Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist, Cell, 129, 579, 10.1016/j.cell.2007.03.023 Tsukada, 2005, Doublecortin association with actin filaments is regulated by neurabin II, J Biol Chem, 280, 11361, 10.1074/jbc.M405525200 Tsukada, 2003, Identification of neurabin II as a novel doublecortin interacting protein, Mech Dev, 120, 1033, 10.1016/S0925-4773(03)00177-1 Shmueli, 2006, Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1), Mol Cell Neurosci, 32, 15, 10.1016/j.mcn.2006.01.014 Tsukada, 2006, Neurabin II mediates doublecortin-dephosphorylation on actin filaments, Biochem Biophys Res Commun, 343, 839, 10.1016/j.bbrc.2006.03.045 Giannakis, 2006, Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches, J Biol Chem, 281, 11292, 10.1074/jbc.M512118200 Cao, 2020, Tuft and cancer stem cell marker DCLK1:a new target to enhance anti-tumor immunity in the tumor microenvironment, Cancers (Basel), 12, E3801, 10.3390/cancers12123801 Ali, 2020, Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism, Sci Rep, 10, 10578, 10.1038/s41598-020-67401-y Maruno, 2021, Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging, Elife, 10, 10.7554/eLife.55117 Kang, 2020, Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: cancer progression and prognosis, World J Gastroenterol, 26, 6853, 10.3748/wjg.v26.i43.6853 Zhang, 2020, DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling, Pflügers Arch Eur J Physiol, 472, 1041, 10.1007/s00424-020-02415-z Buchsbaum, 2003, Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin, J Biol Chem, 278, 18833, 10.1074/jbc.M207876200 Lundberg, 1999, Control of the cell cycle and apoptosis, Eur J Cancer, 35, 1886, 10.1016/S0959-8049(99)00292-0 Vermeulen, 2003, The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Prolif, 36, 131, 10.1046/j.1365-2184.2003.00266.x di Fiore, 2013, RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis, J Cell Physiol, 228, 1676, 10.1002/jcp.24329 Sherr, 2002, The RB and p53 pathways in cancer, Cancer Cell, 2, 103, 10.1016/S1535-6108(02)00102-2 Ben-Porath, 2005, The signals and pathways activating cellular senescence, Int J Biochem Cell Biol, 37, 961, 10.1016/j.biocel.2004.10.013 Ferrer, 2011, Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation, Cell Cycle, 10, 2751, 10.4161/cc.10.16.16422 Aigelsreiter, 2013, Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma, Br J Cancer, 108, 1830, 10.1038/bjc.2013.165 Rubin, 2001, Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1, Oncogene, 20, 3776, 10.1038/sj.onc.1204518 Berndt, 1997, Constitutively active protein phosphatase 1alpha causes Rb-dependent G1 arrest in human cancer cells, Curr Biol, 7, 375, 10.1016/S0960-9822(06)00185-0 Kolupaeva, 2013, PP1 and PP2A phosphatases: cooperating partners in modulating retinoblastoma protein activation, FEBS J, 280, 627, 10.1111/j.1742-4658.2012.08511.x Liu, 1999, Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition, J Biol Chem, 274, 29470, 10.1074/jbc.274.41.29470 Puntoni, 1997, Association of protein phosphatase-1delta with the retinoblastoma protein and reversible phosphatase activation in mitotic HeLa cells and in cells released from mitosis, Biochem Biophys Res Commun, 235, 704, 10.1006/bbrc.1997.6886 Puntoni, 1997, Protein phosphatase-1 alpha, gamma 1, and delta: changes in phosphorylation and activity in mitotic HeLa cells and in cells released from the mitotic block, Arch Biochem Biophys, 340, 177, 10.1006/abbi.1997.9889 Tamrakar, 2000, Role of pRB dephosphorylation in cell cycle regulation, Front Biosci, 5, D121, 10.2741/Tamrakar Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 Rubin, 1998, Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control, Front Biosci, 3, D1209, 10.2741/A357 Nelson, 1997, Characterization of the mitotic phase pRb-directed protein phosphatase activity, Oncogene, 14, 2407, 10.1038/sj.onc.1201081 Fisher, 2014, Phosphatase 1 nuclear targeting subunit is an essential regulator of M-phase entry, maintenance, and exit, J Biol Chem, 289, 23745, 10.1074/jbc.M114.572149 Choy, 2014, Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code, Proc Natl Acad Sci USA, 111, 4097, 10.1073/pnas.1317395111 Tamrakar, 1999, Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity, Oncogene, 18, 7803, 10.1038/sj.onc.1203211 Ludlow, 1993, Specific enzymatic dephosphorylation of the retinoblastoma protein, Mol Cell Biol, 13, 367 Ferrer, 2011, Spinophilin loss contributes to tumorigenesis in vivo, Cell Cycle, 10, 1948, 10.4161/cc.10.12.15798 Ferrer, 2016, Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors, Oncogene, 35, 2777, 10.1038/onc.2015.341 Verdugo-Sivianes, 2017, Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer, Oncotarget, 8, 105196, 10.18632/oncotarget.22111 Mittnacht, 2005, The retinoblastoma protein: from bench to bedside, Eur J Cell Biol, 84, 97, 10.1016/j.ejcb.2004.12.012 Song, 2019, MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas, Theranostics, 9, 6019, 10.7150/thno.35747 Estevez-Garcia, 2013, Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma, Clin Cancer Res, 19, 3925, 10.1158/1078-0432.CCR-13-0057 Molina-Pinelo, 2011, Down-regulation of spinophilin in lung tumours contributes to tumourigenesis, J Pathol, 225, 73, 10.1002/path.2905 Durfee, 1993, The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit, Genes Dev, 7, 555, 10.1101/gad.7.4.555 Ludlow, 1995, Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle, Semin Cancer Biol, 6, 195, 10.1006/scbi.1995.0026 Classon, 2001, p107 and p130:versatile proteins with interesting pockets, Exp Cell Res, 264, 135, 10.1006/excr.2000.5135 Graña, 1998, Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth, Oncogene, 17, 3365, 10.1038/sj.onc.1202575 Bartek, 1996, The retinoblastoma protein pathway and the restriction point, Curr Opin Cell Biol, 8, 805, 10.1016/S0955-0674(96)80081-0 Claudio, 2002, The retinoblastoma family: twins or distant cousins?, Genome Biol, 3, 10.1186/gb-2002-3-9-reviews3012 Mayol, 1998, The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions, Front Biosci, 3, d11, 10.2741/A263 Cobrinik, 2005, Pocket proteins and cell cycle control, Oncogene, 24, 2796, 10.1038/sj.onc.1208619 Feng, 2000, Spinophilin regulates the formation and function of dendritic spines, Proc Natl Acad Sci USA, 97, 9287, 10.1073/pnas.97.16.9287 Aigelsreiter, 2014, Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer, Hum Pathol, 45, 683, 10.1016/j.humpath.2013.11.014 Ress, 2014, Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer, Oncotarget, 5, 8492, 10.18632/oncotarget.2329 Carnero, 2016, The cancer stem-cell signaling network and resistance to therapy, Cancer Treat Rev, 49, 25, 10.1016/j.ctrv.2016.07.001 Cheerathodi, 2016, The cytoskeletal adapter protein spinophilin regulates invadopodia dynamics and tumor cell invasion in glioblastoma, Mol Cancer Res, 14, 1277, 10.1158/1541-7786.MCR-16-0251 Santra, 2006, Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells, Cancer Res, 66, 11726, 10.1158/0008-5472.CAN-06-1978 Santra, 2009, Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion, J Neurochem, 108, 231, 10.1111/j.1471-4159.2008.05758.x Santra, 2011, Effect of doublecortin on self-renewal and differentiation in brain tumor stem cells, Cancer Sci, 102, 1350, 10.1111/j.1349-7006.2011.01952.x Schwarzenbacher, 2015, Low spinophilin expression enhances aggressive biological behavior of breast cancer, Oncotarget, 6, 11191, 10.18632/oncotarget.3586 Jiang, 2010, Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status, J Clin Invest, 120, 3296, 10.1172/JCI41490 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 100, 3983, 10.1073/pnas.0530291100 Kareta, 2015, Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis, Cell Stem Cell, 16, 39, 10.1016/j.stem.2014.10.019 Wang, 2013, Targeting cancer stem cells: emerging role of Nanog transcription factor, Onco Targets Ther, 6, 1207 Zhang, 2016, Insights into the Nanog gene: a propeller for stemness in primitive stem cells, Int J Biol Sci, 12, 1372, 10.7150/ijbs.16349 She, 2017, Cell cycle and pluripotency: convergence on octamer-binding transcription factor 4 (Review), Mol Med Rep, 16, 6459, 10.3892/mmr.2017.7489 Schoeftner, 2013, An Oct4-pRb axis, controlled by miR-335, integrates stem cell self-renewal and cell cycle control, Stem Cells, 31, 717, 10.1002/stem.1315 Comisso, 2017, OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness, Oncogene, 36, 4253, 10.1038/onc.2017.20